Posted On: 01/20/2016 3:54:57 PM
Post# of 223
BioPharmX Corp (BPMX) Director Acquires $18,240.00 in Stock
BioPharmX Corp (NASDAQ:BPMX) Director Stephen Morlock acquired 12,000 shares of the stock in a transaction on Thursday, January 14th. The shares were acquired at an average price of $1.52 per share, with a total value of $18,240.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Stephen Morlock also recently made the following trade(s):
On Tuesday, January 12th, Stephen Morlock acquired 6,000 shares of BioPharmX Corp stock. The shares were acquired at an average price of $1.53 per share, with a total value of $9,180.00.
On Thursday, January 7th, Stephen Morlock acquired 5,000 shares of BioPharmX Corp stock. The shares were acquired at an average price of $1.47 per share, with a total value of $7,350.00.
BioPharmX Corp (NASDAQ:BPMX) Director Stephen Morlock acquired 12,000 shares of the stock in a transaction on Thursday, January 14th. The shares were acquired at an average price of $1.52 per share, with a total value of $18,240.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Stephen Morlock also recently made the following trade(s):
On Tuesday, January 12th, Stephen Morlock acquired 6,000 shares of BioPharmX Corp stock. The shares were acquired at an average price of $1.53 per share, with a total value of $9,180.00.
On Thursday, January 7th, Stephen Morlock acquired 5,000 shares of BioPharmX Corp stock. The shares were acquired at an average price of $1.47 per share, with a total value of $7,350.00.
(0)
(0)
